Ignite Creation Date:
2024-05-06 @ 12:24 AM
Last Modification Date:
2024-10-26 @ 10:49 AM
Study NCT ID:
NCT01567488
Status:
COMPLETED
Last Update Posted:
2018-01-03
First Post:
2012-03-26
Brief Title:
Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET
Sponsor:
Grupo Espanol de Tumores Neuroendocrinos
Organization:
Grupo Espanol de Tumores Neuroendocrinos
Organization Data
Organization:
Grupo Espanol de Tumores Neuroendocrinos
Class:
OTHER
Study ID:
GETNE 1003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Grupo Espanol de Tumores Neuroendocrinos
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None